Question · asked by 1 review
Deferasirox vs placebo: Mortality at any time point
- Population
- people with non‐transfusion‐dependent thalassemia
- Intervention
- Deferasirox
- Comparison
- placebo
- Outcome
- Mortality at any time point
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Deferasirox vs placebo Mortality at any time point · people with non‐transfusion‐dependent thalassemia Deferasirox for managing iron overload in people with thalassaemia (2017) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 148 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Deferasirox for managing iron overload in people with thalassaemia 2017 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Deferasirox vs combined deferasirox and deferiprone · people with transfusion‐dependent thalassemia · 1 review
- Deferasirox vs deferiprone · people with transfusion‐dependent thalassemia · 1 review
- Deferasirox vs deferoxamine · people with transfusion‐dependent thalassemia · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.